醫思健康(02138.HK)預計一季度銷售額增長逾17% 於中國內地服務點總數增加至18個
格隆匯7月25日丨醫思健康(02138.HK)發佈公吿,為滿足中國內地對集團提供美學醫療及美容養生服務的殷切需求,集團已於2022年7月於深圳新開設兩個服務點,新租用樓面面積約12,400平方尺。集團於中國內地的服務點總數增加至18個。集團相信上述服務點之擴張將推動集團中國內地業務的進一步增長,進而鞏固集團於行業中的領先地位。
公司預計截至2022年6月30日止三個月銷售額將不少於8.6億港元,較去年同期升幅不少於17%,較2020年同期升幅不少於80%;季內中國內地服務點之銷售額較去年同期下跌不多於6%,較2020年同期增長不少於29%;及季內集團所提供的醫療服務銷售額較去年同期增長不少於29%,及較2020年同期升幅不少於158%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.